$MYG Mirati Therapeutics, Inc. Insider Trading Week 43/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Mirati Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Mirati Therapeutics, Inc. in week 43/2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | M | 0.00 | 37,051 | 37 | 13,996 | |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | M | 0.00 | 362,952 | 363 | 128,805 | |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | M | 0.00 | 37,051 | 37 | 13,996 | |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Payment of Exercise | F | 219.97 | 2 | 440 | 1,765,560 | 1.8 M to 1.8 M (0.00 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | M | 0.00 | 362,952 | 363 | 128,805 | |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | M | 0.00 | 362,952 | 363 | 1,765,562 | 1.4 M to 1.8 M (+25.88 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Payment of Exercise | F | 219.97 | 2 | 440 | 1,765,560 | 1.8 M to 1.8 M (0.00 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 202.00 | 362,950 | 73,315,900 | 1,404,610 | 1.8 M to 1.4 M (-20.53 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | M | 0.00 | 362,952 | 363 | 1,765,562 | 1.4 M to 1.8 M (+25.88 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Payment of Exercise | F | 219.97 | 1 | 220 | 253,338 | 253.3 K to 253.3 K (0.00 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 202.00 | 362,950 | 73,315,900 | 1,404,610 | 1.8 M to 1.4 M (-20.53 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | M | 0.00 | 37,051 | 37 | 253,339 | 216.3 K to 253.3 K (+17.13 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Payment of Exercise | F | 219.97 | 1 | 220 | 253,338 | 253.3 K to 253.3 K (0.00 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 202.00 | 37,050 | 7,484,100 | 216,288 | 253.3 K to 216.3 K (-14.62 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | M | 0.00 | 37,051 | 37 | 253,339 | 216.3 K to 253.3 K (+17.13 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 104,565 | 105 | 3,590,421 | |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 202.00 | 37,050 | 7,484,100 | 216,288 | 253.3 K to 216.3 K (-14.62 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 295,438 | 295 | 3,694,986 | |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 104,565 | 105 | 3,590,421 | |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Payment of Exercise | F | 202.25 | 1 | 202 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Option Exercise | M | 0.00 | 295,438 | 295 | 3,694,986 | |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 104,565 | 105 | 3,135,967 | 3 M to 3.1 M (+3.45 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Payment of Exercise | F | 202.25 | 1 | 202 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 220.02 | 818 | 179,980 | 3,031,402 | 3 M to 3 M (-0.03 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 104,565 | 105 | 3,135,967 | 3 M to 3.1 M (+3.45 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 218.85 | 663 | 145,098 | 3,032,220 | 3 M to 3 M (-0.02 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 220.02 | 818 | 179,980 | 3,031,402 | 3 M to 3 M (-0.03 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 218.04 | 5,912 | 1,289,025 | 3,032,883 | 3 M to 3 M (-0.19 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 218.85 | 663 | 145,098 | 3,032,220 | 3 M to 3 M (-0.02 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 217.15 | 6,775 | 1,471,157 | 3,038,795 | 3 M to 3 M (-0.22 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 218.04 | 5,912 | 1,289,025 | 3,032,883 | 3 M to 3 M (-0.19 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 216.06 | 11,656 | 2,518,338 | 3,045,570 | 3.1 M to 3 M (-0.38 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 217.15 | 6,775 | 1,471,157 | 3,038,795 | 3 M to 3 M (-0.22 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 215.08 | 27,992 | 6,020,396 | 3,057,226 | 3.1 M to 3.1 M (-0.91 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 216.06 | 11,656 | 2,518,338 | 3,045,570 | 3.1 M to 3 M (-0.38 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 214.31 | 2,344 | 502,335 | 3,085,218 | 3.1 M to 3.1 M (-0.08 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 215.08 | 27,992 | 6,020,396 | 3,057,226 | 3.1 M to 3.1 M (-0.91 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 212.66 | 3,108 | 660,947 | 3,087,562 | 3.1 M to 3.1 M (-0.10 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 214.31 | 2,344 | 502,335 | 3,085,218 | 3.1 M to 3.1 M (-0.08 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 211.50 | 14,408 | 3,047,340 | 3,090,670 | 3.1 M to 3.1 M (-0.46 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 212.66 | 3,108 | 660,947 | 3,087,562 | 3.1 M to 3.1 M (-0.10 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 210.58 | 10,599 | 2,231,945 | 3,105,078 | 3.1 M to 3.1 M (-0.34 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 211.50 | 14,408 | 3,047,340 | 3,090,670 | 3.1 M to 3.1 M (-0.46 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 209.66 | 15,091 | 3,163,970 | 3,115,677 | 3.1 M to 3.1 M (-0.48 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 210.58 | 10,599 | 2,231,945 | 3,105,078 | 3.1 M to 3.1 M (-0.34 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 208.78 | 1,674 | 349,498 | 3,130,768 | 3.1 M to 3.1 M (-0.05 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 209.66 | 15,091 | 3,163,970 | 3,115,677 | 3.1 M to 3.1 M (-0.48 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 207.96 | 1,086 | 225,849 | 3,132,442 | 3.1 M to 3.1 M (-0.03 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 208.78 | 1,674 | 349,498 | 3,130,768 | 3.1 M to 3.1 M (-0.05 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 206.50 | 1,088 | 224,671 | 3,133,528 | 3.1 M to 3.1 M (-0.03 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 207.96 | 1,086 | 225,849 | 3,132,442 | 3.1 M to 3.1 M (-0.03 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 205.65 | 800 | 164,516 | 3,134,616 | 3.1 M to 3.1 M (-0.03 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 206.50 | 1,088 | 224,671 | 3,133,528 | 3.1 M to 3.1 M (-0.03 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 203.32 | 550 | 111,828 | 3,135,416 | 3.1 M to 3.1 M (-0.02 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 205.65 | 800 | 164,516 | 3,134,616 | 3.1 M to 3.1 M (-0.03 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Payment of Exercise | F | 209.16 | 2 | 418 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 203.32 | 550 | 111,828 | 3,135,416 | 3.1 M to 3.1 M (-0.02 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 295,438 | 295 | 3,135,968 | 2.8 M to 3.1 M (+10.40 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Payment of Exercise | F | 209.16 | 2 | 418 | 3,135,966 | 3.1 M to 3.1 M (0.00 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 211.06 | 500 | 105,532 | 2,840,530 | 2.8 M to 2.8 M (-0.02 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Buy | M | 0.00 | 295,438 | 295 | 3,135,968 | 2.8 M to 3.1 M (+10.40 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 210.31 | 23,283 | 4,896,648 | 2,841,030 | 2.9 M to 2.8 M (-0.81 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 211.06 | 500 | 105,532 | 2,840,530 | 2.8 M to 2.8 M (-0.02 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 209.47 | 37,428 | 7,840,043 | 2,864,313 | 2.9 M to 2.9 M (-1.29 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 210.31 | 23,283 | 4,896,648 | 2,841,030 | 2.9 M to 2.8 M (-0.81 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 208.40 | 25,036 | 5,217,502 | 2,901,741 | 2.9 M to 2.9 M (-0.86 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 209.47 | 37,428 | 7,840,043 | 2,864,313 | 2.9 M to 2.9 M (-1.29 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 207.35 | 38,525 | 7,988,159 | 2,926,777 | 3 M to 2.9 M (-1.30 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 208.40 | 25,036 | 5,217,502 | 2,901,741 | 2.9 M to 2.9 M (-0.86 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 206.50 | 41,266 | 8,521,429 | 2,965,302 | 3 M to 3 M (-1.37 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 207.35 | 38,525 | 7,988,159 | 2,926,777 | 3 M to 2.9 M (-1.30 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 205.49 | 45,896 | 9,431,169 | 3,006,568 | 3.1 M to 3 M (-1.50 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 206.50 | 41,266 | 8,521,429 | 2,965,302 | 3 M to 3 M (-1.37 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 204.57 | 38,543 | 7,884,742 | 3,052,464 | 3.1 M to 3.1 M (-1.25 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 205.49 | 45,896 | 9,431,169 | 3,006,568 | 3.1 M to 3 M (-1.50 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 203.35 | 44,959 | 9,142,323 | 3,091,007 | 3.1 M to 3.1 M (-1.43 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 204.57 | 38,543 | 7,884,742 | 3,052,464 | 3.1 M to 3.1 M (-1.25 %) |
Oct 30 2020 | MYG | Mirati Therapeutic ... | Braslyn Ltd. | 10% Owner | Sell | S | 203.35 | 44,959 | 9,142,323 | 3,091,007 | 3.1 M to 3.1 M (-1.43 %) |